Scientists discover gene therapy provides neuroprotection to prevent glaucoma vision loss
Wearable devices can reduce collision risk in blind and visually impaired people
22 July 2021Vision impairment tied to cognitive decline
22 July 2021Scientists discover gene therapy provides neuroprotection to prevent glaucoma vision loss
A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH’s National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and blindness. The report was published in Cell.
